"Get back to where you once belonged": Monitoring the AIDS pandemic in the 21st century

Ciencia e Saude Coletiva

Volumn 13, Issue 6, 2008, Pages 1719-1727

  Bastos, Francisco Inácio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Aids; History of science; Monitoring and evaluation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EPIDEMIC; EPIDEMIOLOGY; HEALTH SURVEY; HUMAN; REVIEW; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE OUTBREAKS; EPIDEMIOLOGIC METHODS; HUMANS; POPULATION SURVEILLANCE;

EID: 53749088168     PISSN: 14138123     EISSN: 16784561     Source Type: Journal    
DOI: 10.1590/S1413-81232008000600007     Document Type: Review

References (34)

1. Castilho EA, Bastos FI. AIDS (1981-1997): O rastro da tormenta. Revista USP 1997; 33: 6-19.
2. Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998; 391(6667):594-597.
3. Bastos FI. AIDS na terceira década. Rio de Janeiro: Fiocruz; 2006.
4. Haile M. Weather patterns, food security and humanitarian response in sub-Saharan Africa. Philos Trans R Soc Lond B Biol Sci. 2005; 360(1463):2169-2182.
5. Gregson S, Mushati P, Nyamukapa C. Adult mortality and erosion of household viability in AIDS-afflicted towns, estates, and villages in eastern Zimbabwe. J Acquir Immune Defic Syndr. 2007;44(2):188-195.
6. White DG, Alekshun MN, McDermott PF, editors. Frontiers in Antimicrobial Resistance: A Tribute to Stuart B. Levy. Washington DC: ASM Press; 2005.
7. Mariani L, Minora T, Ventresca GP. Drug surveillance and adverse reactions to drugs. The literature and importance of historical data; original italiano. Clin Ter. 1996; 147(12):653-672.
8. Lampinen TM, Mattheis K, Chan K, Hogg RS. Nitrite inhalant use among young gay and bisexual men in Vancouver during a period of increasing HIV incidence. BMC Public Health 2007; 7(147):35.
9. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373(6510):123-126.
10. Brookmeyer R & Damiano A. Statistical methods for short-term projections of AIDS incidence. Stat Med. 1989; 8(1):23-34
11. Brookmeyer R, Liao JG. Statistical modelling of the AIDS epidemic for forecasting health care needs. Biometrics 1990; 46(4):1151-1163.
12. Boily MC, Godin G, Hogben M, Sherr L, Bastos FI. The impact of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a new hypothesis to explain recent increases in risk taking-behaviour among men who have sex with men. Med Hypotheses 2005; 65(2):215-226.
13. Artzrouni M. Back-calculation and projection of the HIV/AIDS epidemic among homosexual/ bisexual men in three European countries: evaluation of past projections and updates allowing for treatment effects. Eur J Epidemiol. 2004; 19(2):171-179.
14. Miettinen OS. Theoretical Epidemiology. New York: John Wiley & Sons Inc.; 1985.
15. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol. 1995; 141(2):166-172.
16. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger R. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol. 1995; 142(7):709-713.
17. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280(1):42-48.
18. Rutherford GW, Schwarcz SK, McFarland W. Surveillance for incident HIV infection: new technology and new opportunities. J Acquir Immune Defic Syndr. 2000; 25 (Suppl 2):S115-119.
19. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr. 2003; 33(5):625-634.
20. Young CL, Hu DJ, Byers R, Vanichseni S, Young NL, Nelson R, Mock PA, Choopanya K, Janssen R, Mastro TD, Mei JV. Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res Hum Retroviruses 2003;19(6):481-486.
21. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. Quantitative detection of increasing HIV type 1 antibodies after sero-conversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18(4):295-307.
22. Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res. 2005; 121(4):510-518.
23. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, Kamali A, Sanders EJ, Anzala O, Katende M, Ketter N; the IAVI Collaborative Seroprevalence and Incidence Study Team. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007; 21(4):403-408.
24. Schüpbach J, Gebhardt MD, Tomasik Z, Niederhauser C, Yerly S, Bürgisser P, Matter L, Gorgievski M, Dubs R, Schultze D, Steffen I, Andreutti C, Martinetti G, Güntert B, Staub R, Daneel S, Vernazza P. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Med. 2007; 4(12):e343.
25. Mann J, Tarantola D, Netter T, editors. AIDS in the World. Cambridge: Harvard University Press; 1992.
26. Grangeiro A, Ferraz D, Barbosa R, Barreira D, Veras MA, Villela W, Veloso JC, Nilo A. UNGASS-HIV/AIDS: a review of the Brazilian response, 2001-2005. Rev. Saúde Pública 2006; 40(Suppl):5-8.
27. Ades AE. Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 9(5):490-499.
28. Yan P, Clayton MK. A cluster model for space-time disease counts. Stat Med. 2006; 25(5):867-881.
29. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 2005; 19 (Suppl 2):S67-72.
30. Lazzari S, de Felici A, Sobel H, Bertagnolio S. HIV drug resistance surveillance: summary of an April 2003 WHO consultation. AIDS 2004; 18 (Suppl 3):S49-53.
31. Petersen ML, Boily MC, Bastos FI. Assessing HIV resistance in developing countries: Brazil as a case study. Rev Panam Salud Publica 2006; 19(3):146-156.
32. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006; 43(1):27-34.
33. Klenerman P, Kim A 2007. HCV-HIV coinfection: simple messages from a complex disease. PLoS Med 2007; 4(10):e240.
34. Rainey PM, Friedland GH, Snidow JW, McCance-Katz EF, Mitchell SM, Andrews L, Lane B, Jatlow P. The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects. Am J Addict. 2002; 11(1):66-74.